PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h1m. Bisher sind 420 Folge(n) erschienen. Alle 3 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 17 days 9 hours 32 minutes

subscribe
share





Erik P. Sulman, MD, PhD - Implementing Synergistic Multimodal Approaches With Tumor Treating Fields to Extend Survival in Aggressive Cancers


Go online to PeerView.com/QNS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-12-09  1h8m
 
 

Lynette M. Sholl, MD - Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings


Go online to PeerView.com/KPW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-12-09  58m
 
 
share







 2021-12-07  1h5m
 
 

Jonathan W. Goldman, MD - Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?


Go online to PeerView.com/KBM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-11-30  1h8m
 
 

Prof Eric Van Cutsem, MD, PhD - Putting a Personalized Colorectal Cancer Treatment Algorithm Into Practice: Navigating Practicalities in the Era of Molecularly Defined Care


Go online to PeerView.com/JEN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-11-17  1h10m
 
 

Andrew J. Wagner, MD, PhD - Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team


Go online to PeerView.com/AEC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-11-10  35m
 
 

Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy


Go online to PeerView.com/QRC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-11-06  1h26m
 
 

Peter A. Kouides, MD - Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care With Current and Emerging Management Strategies


Go online to PeerView.com/NRZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-10-26  27m
 
 

Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics


Go online to PeerView.com/ZZW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-10-20  1h20m
 
 

Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC


Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







 2021-10-20  59m